The Jenkins lab received the notice of award for an R21 from the National Institute of Neurological Disorders and Stroke to study the cellular and electrophysiological effects of ANK3 variants identified in a Chinese cohort of epileptic encephalopathy patients. These patients are compound heterozygotes, meaning they have one variant allele from each parent. Very thankful for the support from the NIH!!